Oxidized ATP protection against anthrax lethal toxin

Infection and Immunity

Volumn 74, Issue 7, 2006, Pages 3707-3714

  Moayeri, Mahtab ^a   Wickliffe, Katherine E ^a   Wiggins, Jason F ^a   Leppla, Stephen H ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTHRAX TOXIN; DIPHTHERIA TOXIN; DODECYL SULFATE SODIUM; EDEMA TOXIN; GUANOSINE TRIPHOSPHATE; INOSINE TRIPHOSPHATE; LETHAL TOXIN; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED ADENOSINE DIPHOSPHATE; OXIDIZED ADENOSINE TRIPHOSPHATE; OXIDIZED GUANOSINE TRIPHOSHATE; OXIDIZED INOSINE TRIPHOSPHATE; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; CELL PROTECTION; CHO CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOLYSIS; ENDOSOME; LETHALITY; MACROPHAGE; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; MACROPHAGES; MICE; MICE, INBRED BALB C; OXIDATION-REDUCTION;

EID: 33745588312     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00051-06     Document Type: Article

References (59)

1. Artenstein, A. W., S. M. Opal, P. Cristofaro, J. E. Palardy, N. A. Parejo, M. D. Green, and J. W. Jhung. 2004. Chloroquine enhances survival in Bacillus anthracis intoxication. J. Infect. Dis. 190:1655-1660.
2. Baraldi, P. G., F. Di Virgilio, and R. Romagnoli. 2004. Agonists and antagonists acting at P2X7 receptor. Curr. Top. Med. Chem. 4:1707-1717.
3. Bayer, N., D. Schober, E. Prchla, R. F. Murphy, D. Blaas, and R. Fuchs. 1998. Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection. J. Virol. 72:9645-9655.
4. Beall, F. A., and F. G. Dalldorf. 1966. The pathogenesis of the lethal effect of anthrax toxin in the rat. J. Infect. Dis. 116:377-389.
5. Beigi, R. D., S. B. Kertesy, G. Aquilina, and G. R. Dubyak. 2003. Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br. J. Pharmacol. 140:507-519.
6. Bowman, E. J., A. Siebers, and K. Altendorf. 1988. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA 85:7972-7976.
7. Carroll, S. F., J. T. Barbieri, and R. J. Collier. 1988. Diphtheria toxin: purification and properties. Methods Enzymol. 165:68-76.
8. Chiozzi, P., M. Murgia, S. Falzoni, D. Ferrari, and F. Di Virgilio. 1996. Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures. Biochem. Biophys. Res. Commun. 218:176-181.
9. Collier, R. J., and J. A. T. Young. 2003. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19:45-70.
10. Coutinho-Silva, R., and P. M. Persechini. 1997. P2Z purinoceptor- associated pores induced by extracellular ATP in macrophages and J774 cells. Am. J. Physiol. 273:C1793-C1800.
11. Cui, X., M. Moayeri, Y. Li, X. Li, M. Haley, Y. Fitz, R. Correa-Araujo, S. M. Banks, S. H. Leppla, and P. Q. Eichacker. 2004. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286:R699-R709.
12. Cunningham, K., D. B. Lacy, J. Mogridge, and R. J. Collier. 2002. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc. Natl. Acad. Sci. USA 99:7049-7053.
13. de Melo, D. F., M. Satre, and P. V. Vignais. 1984. Inactivation of beef heart mitochondrial F1-ATPase by the 2′,3′-dialdehyde derivatives of adenine nucleotides. FEBS Lett. 169:101-106.
14. Di Virgilio, F. 2003. Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target. Br. J. Pharmacol. 140:441-443.
15. Di Virgilio, F., P. Chiozzi, S. Falzoni, D. Ferrari, J. M. Sanz, V. Venketaraman, and O. R. Baricordi. 1998. Cytolytic P2X purinoceptors. Cell Death Differ. 5:191-199.
16. Di Virgilio, F., P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi, and O. R. Baricordi. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587-600.
17. Drose, S., K. U. Bindseil, E. J. Bowman, A. Siebers, A. Zeeck, and K. Altendorf. 1993. Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases. Biochemistry 32:3902-3906.
18. Falzoni, S., M. Munerati, D. Ferrari, S. Spisani, S. Moretti, and F. Di Virgilio. 1995. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J. Clin. Investig. 95:1207-1216.
19. Ferrari, D., P. Chiozzi, S. Falzoni, M. Dal Susino, L. Melchiorri, O. R. Baricordi, and F. Di Virgilio. 1997. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159:1451-1458.
20. Ferrari, D., S. Wesselborg, M. K. Bauer, and K. Schulze-Osthoff. 1997. Extracellular ATP activates transcription factor NF-κB through the P2Z purinoreceptor by selectively targeting NF-κB p65. J. Cell Biol. 139:1635-1643.
21. Fish, D. C., F. Klein, R. E. Lincoln, J. S. Walker, and J. P. Dobbs. 1968. Pathophysiological changes in the rat associated with anthrax toxin. J. Infect. Dis. 118:114-124.
22. Fournier, M., B. Labouesse, and J. Labouesse. 1987. Reaction of tryptophanyl-tRNA synthetase from beef pancreas with periodate-oxidized ATP. Eur. J. Biochem. 167:533-540.
23. Friedlander, A. M., R. Bhatnagar, S. H. Leppla, L. Johnson, and Y. Singh. 1993. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect. Immun. 61:245-252.
24. Fulgenzi, A., G. Dell'antonio, C. Foglieni, E. Dal Cin, P. Ticozzi, J. S. Franzone, and M. E. Ferrero. 2005. Inhibition of chemokine expression in rat inflamed paws by systemic use of the antihyperalgesic oxidized ATP. BMC Immunol. 6:18.
25. 2+)-ATPase from Acholeplasma laidlawii B membranes by the 2′,3′-dialdehyde derivative of adenosine 5′- triphosphate. Biochim. Biophys. Acta 813:161-166.
26. 2+-ATPaSe of sarcoplasmic reticulum via the catalytic adenosine-nucleotide-binding site. Eur. J. Biochem. 205:173-179.
27. Huss, M., F. Sasse, B. Kunze, R. Jansen, H. Steinmetz, G. Ingenhorst, A. Zeeck, and H. Wieczorek. 2005. Archazolid and apicularen: novel specific V-ATPase inhibitors. BMC Biochem. 6:13.
28. Ibrahim-Granet, O., B. Philippe, H. Boleti, E. Boisvieux-Ulrich, D. Grenet, M. Stern, and J. P. Latge. 2003. Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect. Immun. 71:891-903.
29. Klein, F., D. R. Hodges, B. G. Mahlandt, W. I. Jones, B. W. Haines, and R. E. Lincoln. 1962. Anthrax toxin: causative agent in the death of rhesus monkeys. Science 138:1331-1333.
30. Klein, F., J. S. Walker, D. F. Fitzpatrick, R. E. Lincoln, B. G. Mahlandt, W. I. Jones, Jr., J. P. Dobbs, and K. J. Hendrix. 1966. Pathophysiology of anthrax. J. Infect. Dis. 116:123-138.
31. Klimpel, K. R., N. Arora, and S. H. Leppla. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100.
32. Lemichez, E., M. Bomsel, G. Devilliers, J. vanderSpek, J. R. Murphy, E. V. Lukianov, S. Olsnes, and P. Boquet. 1997. Membrane translocation of diphtheria toxin fragment A exploits early to late endosome trafficking machinery. Mol. Microbiol. 23:445-457.
33. Leppla, S. H. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 79:3162-3166.
34. Lincoln, R. E., J. S. Walker, F. Klein, A. J. Rosenwald, and W. I. Jones, Jr. 1967. Value of field data for extrapolation in anthrax. Fed. Proc. 26:1558-1562.
35. Liu, S., and S. H. Leppla. 2002. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J. Biol. Chem. 278:5227-5234.
36. Lowe, P. N., and R. B. Beechey. 1982. Interactions between the mitochondrial adenosinetriphosphatase and periodate-oxidized adenosine 5′-triphosphate, an affinity label for adenosine 5′-triphosphate binding sites. Biochemistry 21:4073-4082.
37. McAllister, R. D., Y. Singh, W. D. Du Bois, M. Potter, T. Boehm, N. D. Meeker, P. D. Fillmore, L. M. Anderson, M. E. Poynter, and C. Teuscher. 2003. Susceptibility to anthrax lethal toxin is controlled by three linked quantitative trait loci. Am. J. Pathol. 163:1735-1741.
38. Menard, A., K. Altendorf, D. Breves, M. Mock, and C. Montecucco. 1996. The vacuolar ATPase proton pump is required for the cytotoxicity of Bacillus anthracis lethal toxin. FEBS Lett. 386:161-164.
39. 2+-ATPaSe from sarcoplasmic reticulum by periodate oxidized ATP. Biochim. Biophys. Acta 1039:305-312.
40. Miller, C. J., J. L. Elliott, and R. J. Collier. 1999. Anthrax protective antigen: prepore-to-pore conversion. Biochemistry 38:10432-10441.
41. Moayeri, M., D. Haines, H. A. Young, and S. H. Leppla. 2003. Bacillus anthracis lethal toxin induces TNF-α-independent hypoxia-mediated toxicity in mice. J. Clin. Investig. 112:670-682.
42. Moayeri, M., N. W. Martinez, J. Wiggins, H. A. Young, and S. H. Leppla. 2004. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect. Immun. 72:4439-4447.
43. Murgia, M., S. Hanau, P. Pizzo, M. Rippa, and F. Di Virgilio. 1993. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 268:8199-8203.
44. Murgia, M., P. Pizzo, T. H. Steinberg, and F. Di Virgilio. 1992. Characterization of the cytotoxic effect of extracellular ATP in J774 mouse macrophages. Biochem. J. 288:897-901.
45. Papini, E., R. Rappuoli, M. Murgia, and C. Montecucco. 1993. Cell penetration of diphtheria toxin. Reduction of the interchain disulfide bridge is the rate-limiting step of translocation in the cytosol. J. Biol. Chem. 268:1567-1574.
46. +)-ATPase. J. Biol. Chem. 258:8201-8205.
47. 7 receptor antagonists: Tyrosyl derivatives synthesized using a sequential parallel synthetic approach. Drug Devel. Res. 54:75-87.
48. Rhodes, J., H. Chen, S. R. Hall, J. E. Beesley, D. C. Jenkins, P. Collins, and B. Zheng. 1995. Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature 377:71-75.
49. Sikora, A., J. Liu, C. Brosnan, G. Buell, I. Chessel, and B. R. Bloom. 1999. Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism. J. Immunol. 163:558-561.
50. Steinberg, T. H., A. S. Newman, J. A. Swanson, and S. C. Silverstein. 1987. ATP4 permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J. Biol. Chem. 262:8884-8888.
51. Sytnik, S. K., and A. N. Mal'ian. 1983. Functions and localization of nucleotide-binding sites of CF1-ATPase using dialdehyde derivatives of ADP and ATP. Biokhimiia 48:890-896.
52. Thomson, G. J., J. R. Coggins, and N. C. Price. 1993. The reaction of GroEL (cpn 60) with the ATP analogue 2′,3′ dialdehyde ATP. FEBS Lett. 336:19-22.
53. +-ATPaSe with the a3 isoform during osteoclast differentiation. J. Biol. Chem. 278:22023-22030.
54. +-ATPaSe. J. Biol. Chem. 265:21940-21945.
55. Varughese, M., A. Chi, A. V. Teixeira, P. J. Nicholls, J. M. Keith, and S. H. Leppla. 1998. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Mol. Med. 4:87-95.
56. Walker, J. S., R. E. Lincoln, and F. Klein. 1967. Pathophysiological and biochemical changes in anthrax. Fed. Proc. 26:1539-1544.
57. Westcott, K. R., B. B. Olwin, and D. R. Storm. 1980. Inhibition of adenylate cyclase by the 2′,3′-dialdehyde of adenosine triphosphate. J. Biol. Chem. 255:8767-8771.
58. 2+ signals in pancreatic acinar and beta cells. J. Biol. Chem. 279:7234-7240.
59. +-ATPaSe, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266:17707-17712.